migraines are triggered by calcitonin gene - related peptide ( cgrp ) protein
this widens blood vessels near to the nerves in the head , causing pain
the new injection contains monoclonal blood protein compounds
these are antibodies engineered to bind to cgrp and can ' mop it up '
trials found the treatment significantly reduced migraines in sufferers